Adipokines, insulin resistance, and coronary artery calcification.
暂无分享,去创建一个
[1] A. Hamann,et al. Regulation of energy balance by leptin. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[2] Yu-Cheng Hsieh,et al. Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris. , 2008, International journal of cardiology.
[3] Shuangge Ma,et al. Insulin Resistance, Metabolic Syndrome, and Subclinical Atherosclerosis , 2007, Diabetes Care.
[4] A. Go,et al. Plasma leptin levels and coronary artery calcification in older adults. , 2007, The Journal of clinical endocrinology and metabolism.
[5] S. Kihara,et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.
[6] Anand Rohatgi,et al. Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans , 2007, Journal of Investigative Medicine.
[7] C. Behre. Adiponectin, obesity and atherosclerosis , 2007, Scandinavian journal of clinical and laboratory investigation.
[8] J. Danesh,et al. Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.
[9] M. Cowley,et al. Leptin Resistance and Obesity , 2006, Obesity.
[10] B. Boehm,et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[11] D. Jacobs,et al. Adiponectin, Visceral Fat, Oxidative Stress, and Early Macrovascular Disease: The Coronary Artery Risk Development in Young Adults Study , 2006, Obesity.
[12] W. Kiess,et al. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. , 2005, Best practice & research. Clinical endocrinology & metabolism.
[13] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[14] D. Lawlor,et al. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. , 2005, The Journal of clinical endocrinology and metabolism.
[15] W. Haynes. Role of leptin in obesity‐related hypertension , 2005, Experimental physiology.
[16] B. Howard,et al. Adiponectin and coronary heart disease: the Strong Heart Study. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[17] Anand Rohatgi,et al. Resistin Is an Inflammatory Marker of Atherosclerosis in Humans , 2005, Circulation.
[18] David M Maahs,et al. Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification , 2005, Circulation.
[19] E. Rimm,et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.
[20] Bruce D. Johnson,et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. , 2004, Journal of the American College of Cardiology.
[21] M. Reilly,et al. Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis , 2004, Circulation.
[22] A. Localio,et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.
[23] Nader Rifai,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[24] A. Localio,et al. Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach. , 2004, Atherosclerosis.
[25] A. Localio,et al. C-Reactive Protein and Coronary Artery Calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA) , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[26] Kiang Liu,et al. Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events: A 37-Month Follow-Up of 5635 Initially Asymptomatic Low- to Intermediate-Risk Adults , 2003, Circulation.
[27] J. Engel,et al. Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.
[28] P. Froguel,et al. Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from Atherosclerosis* , 2003, The Journal of Biological Chemistry.
[29] M. Stumvoll,et al. Adiponectin--its role in metabolism and beyond. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[30] N. Sattar,et al. Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.
[31] P. Rizzon,et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery , 2001, International Journal of Obesity.
[32] F. Parhami,et al. Leptin Enhances the Calcification of Vascular Cells: Artery Wall as a Target of Leptin , 2001, Circulation research.
[33] NoriyukiOuchi,et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001 .
[34] S. Kihara,et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.
[35] E. Rimm,et al. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men , 2000, International Journal of Obesity.
[36] M. Laule,et al. Elevated serum leptin in patients with coronary artery disease: no association with the Trp64Arg polymorphism of the β3-adrenergic receptor , 2000, International Journal of Obesity.
[37] T. Olsson,et al. Leptin is associated with increased risk of myocardial infarction , 1999, Journal of internal medicine.
[38] S. Coppack,et al. Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.
[39] G. Dagenais,et al. Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.
[40] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[41] S. Klein,et al. Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men , 1996, Diabetes.
[42] M A Proschan,et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. , 1994, Radiology.
[43] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[44] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[45] NoriyukiOuchi,et al. Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003 .
[46] M. Bots,et al. Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.
[47] J. Tobin. Estimation of Relationships for Limited Dependent Variables , 1958 .